This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2025 May 27;104(10):e213672.

doi: 10.1212/WNL.0000000000213672. Epub 2025 Apr 23.

A Newly Validated Gold Standard for Measuring Multiple Sclerosis Disability Worsening

Robert J Fox¹, Richard A Rudick²

Affiliations

PMID: 40266716
DOI: 10.1212/WNL.0000000000213672

Editorial

A Newly Validated Gold Standard for Measuring Multiple Sclerosis Disability Worsening

Robert J Fox et al. Neurology. 2025.

. 2025 May 27;104(10):e213672.

doi: 10.1212/WNL.0000000000213672. Epub 2025 Apr 23.

Authors

Robert J Fox¹, Richard A Rudick²

Affiliations

¹ Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, OH; and.
² Astoria Biologica Inc, Norwalk, CT.

PMID: 40266716
DOI: 10.1212/WNL.0000000000213672

No abstract available

PubMed Disclaimer

Comment on

Composite Confirmed Disability Worsening/Progression Is a Useful Clinical Endpoint for Multiple Sclerosis Clinical Trials.
Kappos L, Yiu S, Dahlke F, Coetzee T, Cutter GR, Yuen S, Bonati U, Lublin FD. Kappos L, et al. Neurology. 2025 May 27;104(10):e213558. doi: 10.1212/WNL.0000000000213558. Epub 2025 Apr 21. Neurology. 2025. PMID: 40258203 Free PMC article.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.